Article Permissions

 

The three bidders for Unilabs compared

Two strategics and a private equity player are bidding for Unilabs, the Pan-European, Mid East and LaTam lab and imaging group. So who is likely to win?

HBI 2020: Dentistry – will we see a truly pan-European group and the COVID bounce back?

At the start of this year, there was a lot of optimism around dentistry. The dental sector was seen as one of the biggest and most exciting opportunities for private operators and investors. Largely unconsolidated across Europe and beyond, many asked ‘when will we see a truly pan-European operator'? COVID derailed all expectations of the year but with a vaccine now in play, what are the prospects for consolidation and expansion? HBI 2020 gathered a panel of experts to find out more.

HBI 2020: Medtech and services – new partnerships and opportunities

The relationship between medtech and its customers is changing. No longer is medtech wheeled out for a one-off purchase. Long-term partnerships are being built, and patients and providers are benefitting. An expert panel at HBI 2020 explored the burgeoning relationship between medtech and services, and some of the challenges this presented.

Interview: Arjan Toor, CEO, Cigna Europe

Cigna now describes itself as “a global health service company” rather than an insurer and has reorganised its European operations. Toor has recently been promoted to CEO Europe. He says that the insurer, which has 15% (US$840m) of its revenue in Europe, doesn't want to verticalise through owning primary care providers but wants instead to provide an end-to-end user experience.

Asklepios set to win control of Rhoen

Asklepios has effectively taken over Rhoen Klinikum after B Braun with a 25% stake accepted the offer. The deal increases the consolidation in the private hospital sector.

Alvarez & Marsal to sell NMC’s fertility arm

NMC Health Plc’s administrators have started selling off parts of the business according to Bloomberg with an auction of the fertility business as early as June. Consultants Alvarez & Marsal who are handling the business have invited bids for NMC’s distribution business according to the article. Potential acquirers have been asked to submit offers this […]

COVID-19 and Emerging Market healthcare

We talk to two of the world's largest investors in emerging market health care about Covid's likely impact. Despite so far much lower death rates, the initial effect on health care operators has been worse than in Europe. Covid is set to destroy several motors for growth such as healthcare tourism and the deployment of […]

Health care service write-offs drive losses at Bupa

Bupa, the global healthcare insurer and healthcare operator went from pre-tax profits of £502m in 2018 to a loss of £78m in 2019, thanks mainly to huge write-offs in its UK dentistry business and Australian care homes. But stripping out write-offs, underlying profitability still plunged 31%. Revenue rose just 4%. Why, and what does this tell us about Bupa and its future?

NMC identifies $335m side deals and sacks CEO

In an announcement put out after trading, the independent review board appointed by NMC has identified side deals on procurement worth US$335m with the founders for which NMC is liable and that were made without board approval. It has also removed Mr Prasanth Manghat from his position of Director and CEO of the Company with immediate effect.

EBITDA crash for German hospitals

One of the foremost experts on the German hospital sector predicts that recent legislation from health minister Jens Spahn will see EBITDA  at for-profit hospitals crash by around a fifth.

Find Us